{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:51:04Z","timestamp":1759341064946},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T00:00:00Z","timestamp":1388707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s12032-013-0831-1","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T08:19:45Z","timestamp":1388650785000},"source":"Crossref","is-referenced-by-count":10,"title":["Benign reversible encephalopathy syndrome after bevacizumab therapy for metastatic ovarian cancer"],"prefix":"10.1007","volume":"31","author":[{"given":"R.","family":"Sawaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,3]]},"reference":[{"issue":"7","key":"831_CR1","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00415-011-6362-9","volume":"259","author":"O Kastrup","year":"2012","unstructured":"Kastrup O, Gerwig M, Frings M, Diener HC. Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns. J Neurol. 2012;259(7):1383\u20139.","journal-title":"J Neurol"},{"issue":"3","key":"831_CR2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/practneurol-2011-000010","volume":"11","author":"C Roth","year":"2011","unstructured":"Roth C, Ferbert A. The posterior reversible encephalopathy syndrome: what's certain, what's new? Pract Neurol. 2011;11(3):136\u201344.","journal-title":"Pract Neurol"},{"issue":"10","key":"831_CR3","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archneur.63.10.1475","volume":"63","author":"JA Allen","year":"2006","unstructured":"Allen JA, Adlakha A, Bergethon PR. Reversible posterior leukoencephalopathy syndrome after bevacizumab\/FOLFIRI regimen for metastatic colon cancer. Arch Neurol. 2006;63(10):1475\u20138.","journal-title":"Arch Neurol"},{"issue":"9","key":"831_CR4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJMc052954","volume":"354","author":"P Glusker","year":"2006","unstructured":"Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med. 2006;354(9):980\u20132.","journal-title":"N Engl J Med"},{"issue":"4","key":"831_CR5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11523-011-0201-x","volume":"6","author":"C Tlemsani","year":"2011","unstructured":"Tlemsani C, Mir O, Boudou-Rouquette P, Huillard O, Maley K, Ropert S, Coriat R, Goldwasser F. Posterior reversible encephalopathy syndrome induced by anti-VEGF agents. Target Oncol. 2011;6(4):253\u20138.","journal-title":"Target Oncol"},{"issue":"1","key":"831_CR6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/qjmed\/hcr139","volume":"105","author":"RC Seet","year":"2012","unstructured":"Seet RC, Rabinstein AA. Clinical features and outcomes of posterior reversible encephalopathy syndrome following bevacizumab treatment. QJM. 2012;105(1):69\u201375.","journal-title":"QJM"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0831-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-013-0831-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0831-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:22:28Z","timestamp":1559427748000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-013-0831-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,3]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1007\/s12032-013-0831-1","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,3]]},"article-number":"831"}}